Open AccessImpaired intestinal iron absorption in Crohn's disease correlates with disease activity and markers of inflammation
Author(s) -
Semrin Gaith,
Fishman Douglas S.,
Bousvaros Athos,
Zholudev Anna,
Saunders Andrew C.,
Correia Catherine E.,
Nemeth Elizabeta,
Grand Richard J.,
Weinstein David A.
Publication year - 2006
Publication title -
inflammatory bowel diseases
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.932
H-Index - 146
eISSN - 1536-4844
pISSN - 1078-0998
DOI - 10.1097/01.mib.0000235097.86360.04
Subject(s) - hepcidin , medicine , anemia , erythrocyte sedimentation rate , inflammation , c reactive protein , hemoglobin , urine , serum iron , iron deficiency , iron deficiency anemia , area under the curve , inflammatory bowel disease , endocrinology , gastroenterology , disease
Background: Anemia in patients with Crohn's disease (CD) is a common problem of multifactorial origin, including blood loss, malabsorption of iron, and anemia of inflammation. Anemia of inflammation is caused by the effects of inflammatory cytokines [predominantly interleukin‐6 (IL‐6)] on iron transport in enterocytes and macrophages. We sought to elucidate alterations in iron absorption in pediatric patients with active and inactive CD. Methods: Nineteen subjects with CD (8 female, 11 male patients) were recruited between April 2003 and June 2004. After an overnight fast, serum iron and hemoglobin levels, serum markers of inflammation [IL‐6, C‐reactive protein (CRP), and erythrocyte sedimentation rate], and a urine sample for hepcidin assay were obtained at 8 am. Ferrous sulfate (1 mg/kg) was administered orally, followed by determination of serum iron concentrations hourly for 4 hours after the ingestion of iron. An area under the curve for iron absorption was calculated for each patient data set. Results: There was a strong inverse correlation between the area under the curve and IL‐6 ( P = 0.002) and area under the curve and CRP levels ( P = 0.04). Similarly, the difference between baseline and 2‐hour serum iron level (Δ[Fe]2hr) correlated with IL‐6 ( P = 0.008) and CRP ( P = 0.045). When cutoff values for IL‐6 (>5 pg/mL) and CRP (>1.0 mg/dL) were used, urine hepcidin levels also positively correlated with IL‐6 and CRP levels ( P = 0.003 and 0.007, respectively). Conclusions: Subjects with active CD have impaired oral iron absorption and elevated IL‐6 levels compared with subjects with inactive disease. These findings suggest that oral iron may be of limited benefit to these patients. Future study is needed to define the molecular basis for impaired iron absorption.